COVID-19 Variant Supplement - Development of a rapid point-of-care diagnostic test for COVID-19

COVID-19 变异补充品 - 开发针对 COVID-19 的快速护理点诊断测试

• 批准号: 443034
• 负责人: Berezovski Maxim
• 金额: $ 3.64万
• 依托单位: University of Ottawa
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-02-01 至 2022-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=443034&lang=en
• 关键词: Antiviral Aptamers; Aptamer-Assisted Graphene Oxide (Aptago) Tests; Coronavirus Disease 2019; Diagnostics; Paper-Based Enzyme-Linked Aptamer Assays (P-Elaa); Sars-Cov-2 Virus Proteins (S- And N-Proteins); Viable Human Coronavirus 229e

A novel zoonotic coronavirus (SARS-CoV-2) has recently been identified in patients with an acute and potentially fatal respiratory disease (COVID-19). This virus is genetically similar to SARS and MERS coronaviruses. The outbreak started in the city of Wu

最近在患有急性致命呼吸道疾病的患者中发现了一种新型的人畜共努性冠状病毒（SARS-COV-2）（COVID-19）。该病毒在遗传上类似于SARS和MERS冠状病毒。爆发始于吴市